Earnings NewsHealthcareEliem Therapeutics GAAP EPS of -$0.40Mar. 07, 2022 4:29 PM ETEliem Therapeutics, Inc. (ELYM)By: SA News Team Eliem Therapeutics press release (NASDAQ:ELYM): Q4 GAAP EPS of -$0.40. Cash, cash equivalents and marketable securities was $161.4M as of December 31, 2021. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.